Generic placeholder image

Current Topics in Medicinal Chemistry


ISSN (Print): 1568-0266
ISSN (Online): 1873-4294


Development and Advances of Drugs for Cancer Theranostics – PART-III

Author(s): Lian-Shun Feng

Volume 21 , Issue 5 , 2021

Published on: 16 February, 2021

Page: [347 - 347] Pages: 1

DOI: 10.2174/156802662105210216122217

Next »
Hulvat. M.C. Cancer incidence and Trends. Surg. Clin. N Am., 2020, 100(3), 469-481.
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin., 2020, 70(1), 7-30.
Birudukota, N.; Mudgal, M.M.; Shanbhag, V. Discovery and development of azasteroids as anticancer agents. Steroids, 2019, 152e108505
Pulte, D.; Weberpals, J.; Jansen, L.; Brenner, H. Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century. Cancer, 2019, 125(15), 2656-2665.
Kerru, N.; Singh, P.; Koornanally, N.; Raj, R.; Kumar, V. Recent advances (2015-2016) in anticancer hybrids. Eur. J. Med. Chem., 2017, 142, 179-212.
Dallavalle, S.; Dobricic, V.; Lazzarato, L.; Gazzano, E.; Machuqueiro, M.; Pajeva, I.; Tsakovska, I.; Zidar, Z.; Fruttero, R. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist. Update., 2020, 50e100682
Dong, J.; Zhang, Q.; Wang, Z.; Huang, G.; Li, S. Recent advances in the development of indazole-based anticancer agents. ChemMedChem, 2018, 13(15), 1490-1507.
Dadashpour, S.; Emami, S. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. Eur. J. Med. Chem., 2018, 150, 9-29.
Efferth, T.; Saeed, M.E.M.; Kadioglu, O.; Seo, E.J.; Shirooie, S.; Mbaveng, A.T.; Nababi, S.M.; Kuete, V. Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnol. Adv., 2020, 38e107342
Waghray, D.; Zhang, Q. Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment. J. Med. Chem., 2018, 61(12), 5108-5121.

© 2022 Bentham Science Publishers | Privacy Policy